AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Apr 13, 2011
33422_dirs_2011-04-12_eecfedfc-f877-42ca-bdd6-9364043c811e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRO PHARMACEUTICALS INC (PRWP.OB)
CIK: 0001133416
Period of Report: 2011-04-08
Reporting Person: ZUCCONI THEODORE DANIEL (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-08 | Employee Stock Option (right to buy) | $1.32 | A | 300000 | Acquired | 2018-04-08 | Common Stock (300000) | Direct |
Footnotes
F1: The Option vests in up to three 100,000 share installments upon incentive objectives achieved by the reporting person on or before March 31, 2012.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21